This company listing is no longer active
Atreca Yönetim
Yönetim kriter kontrolleri 3/4
Atreca's CEO is John Orwin, appointed in Apr 2018, has a tenure of 6.17 years. total yearly compensation is $927.03K, comprised of 64.8% salary and 35.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth €3.37K. The average tenure of the management team and the board of directors is 5 years and 5.5 years respectively.
Anahtar bilgiler
John Orwin
İcra Kurulu Başkanı
US$927.0k
Toplam tazminat
| CEO maaş yüzdesi | 64.8% |
| CEO görev süresi | 6.2yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 5yrs |
| Yönetim Kurulu ortalama görev süresi | 5.5yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$98m |
| Jun 30 2023 | n/a | n/a | -US$85m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$927k | US$601k | -US$97m |
| Sep 30 2022 | n/a | n/a | -US$105m |
| Jun 30 2022 | n/a | n/a | -US$110m |
| Mar 31 2022 | n/a | n/a | -US$108m |
| Dec 31 2021 | US$4m | US$583k | -US$109m |
| Sep 30 2021 | n/a | n/a | -US$103m |
| Jun 30 2021 | n/a | n/a | -US$98m |
| Mar 31 2021 | n/a | n/a | -US$92m |
| Dec 31 2020 | US$5m | US$567k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$76m |
| Mar 31 2020 | n/a | n/a | -US$74m |
| Dec 31 2019 | US$845k | US$507k | -US$67m |
| Sep 30 2019 | n/a | n/a | -US$59m |
| Jun 30 2019 | n/a | n/a | -US$53m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$5m | US$319k | -US$38m |
Tazminat ve Piyasa: John's total compensation ($USD927.03K) is above average for companies of similar size in the German market ($USD434.04K).
Tazminat ve Kazançlar: John's compensation has been consistent with company performance over the past year.
CEO
John Orwin (59 yo)
6.2yrs
Görev süresi
US$927,033
Tazminat
Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Independent Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has be...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | no data | US$665.50k | 0.81% € 14.0k | |
| Principal Accounting Officer | less than a year | Veri yok | Veri yok | |
| General Counsel & Corporate Secretary | 5yrs | Veri yok | 0.073% € 1.3k | |
| Vice President of Finance | no data | Veri yok | 0.067% € 1.2k |
5.0yrs
Ortalama Görev Süresi
59.5yo
Ortalama Yaş
Deneyimli Yönetim: 0C1's management team is seasoned and experienced (5 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | 14.4yrs | US$665.50k | 0.81% € 14.0k | |
| Independent Chairman of the Board | 10.5yrs | US$97.77k | 0.13% € 2.2k | |
| Chairman of External Scientific Advisory Board & Technical Advisor | 4.8yrs | US$150.00k | Veri yok | |
| Independent Director | 4.1yrs | US$64.27k | 0% € 0 | |
| Director | 13.4yrs | US$312.77k | 0.93% € 16.0k | |
| Independent Director | 8.1yrs | US$70.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$60.27k | 0% € 0 | |
| Board Observer | no data | Veri yok | Veri yok | |
| Board Observer | no data | Veri yok | Veri yok | |
| Independent Director | 4.8yrs | US$62.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$57.77k | 0% € 0 |
5.5yrs
Ortalama Görev Süresi
57.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 0C1's board of directors are considered experienced (5.5 years average tenure).